Bovine Herpesvirus-4-Based Vector Delivering Peste des Petits Ruminants Virus Hemagglutinin ORF Induces both Neutralizing Antibodies and Cytotoxic T Cell Responses

Peste des Petits Ruminants Virus (PPRV) is an extremely infective morbillivirus that primarily affects goats and sheep. In underdeveloped countries where livestock are the main economical resource, PPRV causes considerable economic losses. Protective live attenuated vaccines are currently available but they induce antibody responses similar to those produced in PPRV naturally infected animals. Effective vaccines able to distinguish between vaccinated and naturally infected animals are required to PPRV control and eradication programs. Hemagglutinin (H) is a highly immunogenic PPRV envelope glycoprotein displaying both hemagglutinin and neuraminidase activities, playing a crucial role in virus attachment and penetration. In this study, a recombinant Bovine Herpesvirus-4 (BoHV-4)-based vector delivering an optimized PPRV-Hemagglutinin expression cassette, BoHV-4-A-PPRV-H-ΔTK, was assessed in immunocompetent C57BL/6 mice. BoHV-4-A-PPRV-H-ΔTK-immunization elicited both cellular and humoral immune responses with specific T cell, cytotoxic T lymphocyte, and sero-neutralizing antibody against PPRV. These data suggest recombinant BoHV-4-A-PPRV-H-ΔTK as an effective vaccine candidate to protect against PPRV herd infection and potentially applicable for eradication programs.

• Publication year

  2018

• Venue

  Frontiers in Immunology

• Publication date

  2018-03-05

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3389/fimmu.2018.00421PMID 29556236PMCID 5845008
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Vaccination with recombinant adenovirus expressing peste des petits ruminants virus-F or -H proteins elicits T cell responses to epitopes that arises during PPRV infection

  2017cited by this paper
• Peste des Petits Ruminants Virus.

  2016cited by this paper
• PI3K p85 β regulatory subunit deficiency does not affect NK cell differentiation and increases NKG2D‐mediated activation

  2016cited by this paper
• Livestock vaccinations translate into increased human capital and school attendance by girls

  2016cited by this paper
• Bovine herpesvirus 4-based vector delivering a hybrid rat/human HER-2 oncoantigen efficiently protects mice from autochthonous Her-2+ mammary cancer

  2015cited by this paper
• BoHV-4-Based Vector Single Heterologous Antigen Delivery Protects STAT1(-/-) Mice from Monkeypoxvirus Lethal Challenge

  2015cited by this paper
• Ovine and murine T cell epitopes from the non-structural protein 1 (NS1) of bluetongue virus serotype 8 (BTV-8) are shared among viral serotypes

  2014cited by this paper
• Two replication-defective adenoviral vaccine vectors for the induction of immune responses to PPRV.

  2014cited by this paper
• Retinal transduction profiles by high-capacity viral vectors

  2014cited by this paper
• Vaccination with Recombinant Adenoviruses Expressing the Peste des Petits Ruminants Virus F or H Proteins Overcomes Viral Immunosuppression and Induces Protective Immunity against PPRV Challenge in Sheep

  2014cited by this paper
• In Vivo Image Analysis of BoHV-4-Based Vector in Mice

  2014cited by this paper
• Recombinant adenovirus expressing the haemagglutinin of peste des petits ruminants virus (PPRV) protects goats against challenge with pathogenic virus; a DIVA vaccine for PPR

  2014cited by this paper
• Clinical Protection of Goats against CpHV-1 Induced Genital Disease with a BoHV-4-Based Vector Expressing CpHV-1 gD

  2013cited by this paper
• How to calculate sample size in animal studies?

  2013cited by this paper
• Bovine Endometrial Stromal Cells Support Tumor Necrosis Factor Alpha-Induced Bovine Herpesvirus Type 4 Enhanced Replication1

  2013cited by this paper
• Measles humoral and cell-mediated immunity in children aged 5-10 years after primary measles immunization administered at 6 or 9 months of age.

  2013cited by this paper
• A Novel Recombinant Peste des Petits Ruminants-Canine Adenovirus Vaccine Elicits Long-Lasting Neutralizing Antibody Response against PPR in Goats

  2012cited by this paper
• Herpes simplex virus type 1 thymidine kinase-armed bovine herpesvirus type 4-based vector displays enhanced oncolytic properties in immunocompetent orthotopic syngenic mouse and rat glioma models.

  2012cited by this paper
• Immunization of knock-out α/β interferon receptor mice against lethal bluetongue infection with a BoHV-4-based vector expressing BTV-8 VP2 antigen.

  2011cited by this paper
• Swine adipose stromal cells loaded with recombinant bovine herpesvirus 4 virions expressing a foreign antigen induce potent humoral immune responses in pigs.

  2011cited by this paper
• T cell responses to bluetongue virus are directed against multiple and identical CD4+ and CD8+ T cell epitopes from the VP7 core protein in mouse and sheep.

  2011cited by this paper
• The Chemokine IL8 Is Up-Regulated in Bovine Endometrial Stromal Cells by the BoHV-4 IE2 Gene Product, ORF50/Rta: A Step Ahead Toward a Mechanism for BoHV-4 Induced Endometritis1

  2010cited by this paper
• A goat poxvirus-vectored peste-des-petits-ruminants vaccine induces long-lasting neutralization antibody to high levels in goats and sheep.

  2010cited by this paper
• Specific CD8+ T‐lymphocytes control dissemination of measles virus

  2010cited by this paper
• Comparative efficacy of peste des petits ruminants (PPR) vaccines.

  2010cited by this paper
• Cellular Targeting of Engineered Heterologous Antigens Is a Determinant Factor for Bovine Herpesvirus 4-Based Vaccine Vector Development

  2009cited by this paper
• Double immunization strategy with a BoHV-4-vectorialized secreted chimeric peptide BVDV-E2/BoHV-1-gD.

  2008cited by this paper
• Bacterial infection of endometrial stromal cells influences bovine herpesvirus 4 immediate early gene activation: a new insight into bacterial and viral interaction for uterine disease.

  2008cited by this paper
• The threat of peste des petits ruminants: progress in vaccine development for disease control.

  2007cited by this paper
• Establishment of a Bovine Herpesvirus 4 based vector expressing a secreted form of the Bovine Viral Diarrhoea Virus structural glycoprotein E2 for immunization purposes

  2007cited by this paper
• Bovine herpesvirus 4 based vector interaction with liver cells in vitro and in vivo.

  2006cited by this paper
• A bivalent vaccine against goat pox and Peste des Petits ruminants induces protective immune response in goats.

  2006cited by this paper
• Evolution of Bovine herpesvirus 4: recombination and transmission between African buffalo and cattle.

  2006cited by this paper
• Bovine herpesvirus 4-associated postpartum metritis in a Spanish dairy herd.

  2006cited by this paper
• Outcome of bovine herpesvirus 4 infection following direct viral injection in the lateral ventricle of the mouse brain.

  2006cited by this paper
• Simple and highly efficient BAC recombineering using galK selection

  2005cited by this paper
• Efficient Isolation of Wild Strains of Canine Distemper Virus in Vero Cells Expressing Canine SLAM (CD150) and Their Adaptability to Marmoset B95a Cells

  2003cited by this paper
• Development of a DIVA (Differentiating Infected from Vaccinated Animals) strategy using a vaccine containing a heterologous neuraminidase for the control of avian influenza

  2003cited by this paper
• Development of a Dual Recombinant Vaccine To Protect Small Ruminants against Peste-des-Petits-Ruminants Virus and Capripoxvirus Infections

  2003cited by this paper
• Seroprevalence and Comparison of Isolates of Endometriotropic Bovine Herpesvirus-4

  2002cited by this paper
• Goat Immune Response to Capripox Vaccine Expressing the Hemagglutinin Protein of Peste des Petits Ruminants

  2002cited by this paper
• Potential of bovine herpesvirus 4 as a gene delivery vector.

  2002cited by this paper
• Duration of the protection of an E2 subunit marker vaccine against classical swine fever after a single vaccination.

  2001cited by this paper
• Efficacy of the classical swine fever (CSF) marker vaccine Porcilis Pesti in pregnant sows.

  2000cited by this paper
• Vaccination of cattle with attenuated rinderpest virus stimulates CD4(+) T cell responses with broad viral antigen specificity.

  2000cited by this paper
• Antigen-Specific Expansion of Cytotoxic T Lymphocytes in Acute Measles Virus Infection

  1999cited by this paper
• Histological studies of bovine herpesvirus type 4 infection in non-ruminant species.

  1997cited by this paper
• Sequence and structure alignment of Paramyxoviridae attachment proteins and discovery of enzymatic activity for a morbillivirus hemagglutinin

  1997cited by this paper
• Protection of goats against peste des petits ruminants with a vaccinia virus double recombinant expressing the F and H genes of rinderpest virus.

  1993cited by this paper
• Antigenic and genomic identity between simian herpesvirus aotus type 2 and bovine herpesvirus type 4.

  1991cited by this paper
• A bovine herpesvirus (BHV-4) as passenger virus in ethmoidal tumours in Indian cattle.

  1989cited by this paper
• Immunization with a vaccinia recombinant expressing the F protein protects rabbits from challenge with a lethal dose of rinderpest virus.

  1989cited by this paper
• Isolation of a virus from a female cat with urolithiasis.

  1971cited by this paper

• A Single Dose of Live-Attenuated Rift Valley Fever Virus Vector Expressing Peste Des Petits Ruminants Virus (PPRV) H or F Antigens Induces Immunity in Sheep

  2025cites this paper
• Potential of Bovine Herpesvirus Vectors for Recombinant Vaccines

  2025cites this paper
• Bovine Herpesvirus-4 Based Vaccine Provides Protective Immunity against Streptococcus suis Disease in a Rabbit Model

  2023influential citation
• Characterization and phylogenetic analysis of bovine gammaherpesvirus 4 isolated in China, 2022

  2023cites this paper
• Epidemiological survey of bovine gammaherpesvirus 4 (BoHV-4) infection in cattle and buffalo from Pakistan

  2022cites this paper
• A Novel Rabies Vaccine Based on a Recombinant Bovine Herpes Virus Type 1 Expressing Rabies Virus Glycoprotein

  2022influential citation
• Immunization With Bovine Herpesvirus-4-Based Vector Delivering PPRV-H Protein Protects Sheep From PPRV Challenge

  2021cites this paper
• Vaccination With Recombinant Adenoviruses Expressing the Bluetongue Virus Subunits VP7 and VP2 Provides Protection Against Heterologous Virus Challenge

  2021cites this paper
• A New Look at Vaccine Strategies Against PPRV Focused on Adenoviral Candidates

  2021cites this paper
• Bovine Herpesvirus-4-Vectored Delivery of Nipah Virus Glycoproteins Enhances T Cell Immunogenicity in Pigs

  2020cites this paper
• Bovine Herpesvirus Type 4 (BoHV-4) Vector Delivering Nucleocapsid Protein of Crimean-Congo Hemorrhagic Fever Virus Induces Comparable Protective Immunity against Lethal Challenge in IFNα/β/γR−/− Mice Models

  2019cites this paper
• Toward peste des petits virus (PPRV) eradication: diagnostic approaches, novel vaccines, and control strategies.

  2019cites this paper
• Bovine Herpesvirus type 4 ( BoHV-4 ) Vector Delivering Nucleocapsid 1 Protein of Crimean Congo Hemorrhagic Fever Virus Induces Comparable 2 Protective Immunity against Lethal Challenge in IFNAR-/-Mice Model 3 4

  2019cites this paper
• Utilization of Herpesviridae as Recombinant Viral Vectors in Vaccine Development against Animal Pathogens.

  2019cites this paper
• A recombinant bovine herpesvirus-4 vectored vaccine delivered via intranasal nebulization elicits viral neutralizing antibody titers in cattle

  2019cites this paper